Zimmer Biomet 2019 sales hit $8 billion: 7 things to know

Spinal Tech

Zimmer Biomet reported a slight increase in fourth quarter and full year sales in 2019, reporting a strong performance in hips, knees and robotic system sales. 

Seven things to know:

1. Fourth quarter sales were up 2.6 percent to $2.1 billion, with knee products leading the way. Knee product sales were up nearly 4.3 percent to $761 million during the quarter, while hips were up 2.7 percent to $511 million. Spine and craniomaxillofacial sales were down 0.3 percent to $197 million.

2. Full year sales were up 0.8 percent to nearly $8 billion. Knee sales were up 1.3 percent to $2.8 billion while hip sales were up 0.7 percent to $1.9 billion. Full year spine and craniomaxillofacial sales were down 2.2 percent to $747 million.

3. Sales in the Americas were up 0.8 percent for the year, hitting $4.8 billion. The European sales were down 3.1 percent, but Asian Pacific sales were up 5.1 percent.

4. During 2019, Zimmer Biomet paid down $716 million of debt, net of debt proceeds, and paid $197 million in dividends. The company reported operating cash flow at $423 million and free cash flow of $295 million for the fourth quarter.

5. Zimmer Biomet expects 2020 reported revenue to increase 2.5 percent to 3.5 percent.

6. Net earnings for 2019 were $1.1 billion, up from $379.2 million net loss in 2018.

7. The Rosa Knee System, the company's robotic knee system, accelerated sales from the third to the fourth quarter.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like